Sale!

Everolimus Test Cost

Original price was: 1,200 د.إ.Current price is: 1,020 د.إ.

-15%

The Everolimus Test is a specialized diagnostic procedure designed to measure the levels of everolimus, a potent immunosuppressant drug, in the blood. This test is crucial for individuals who are undergoing treatment with everolimus, particularly patients who have undergone organ transplantation or those being treated for certain types of cancers. By monitoring the concentration of the drug, healthcare providers can adjust dosages to optimize therapeutic effects while minimizing potential side effects.

The test involves a simple blood draw, after which the sample is analyzed to determine the concentration of everolimus present. This helps in ensuring that the drug levels remain within a therapeutic range, which is essential for the efficacy of the treatment and the safety of the patient.

At DNA Labs UAE, the Everolimus Test is available for a cost of 1020 AED. The facility is equipped with state-of-the-art technology to ensure accurate and reliable results. DNA Labs UAE is known for its commitment to providing high-quality diagnostic services, making it a trusted choice for patients and healthcare providers seeking to monitor everolimus levels.

Description

EVEROLIMUS Test Cost AED:1020.0 Symptoms Diagnosis

Test Name: EVEROLIMUS Test

Components: Price 1020.0 AED

Sample Condition: 3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. Provide date and time of sampling, amount & time of dose. Ideal sampling time: 1 hour before next dose (12 hour trough).

Report Delivery: Sample Daily by 5 pm; Report Same day

Method: LC-MS/MS

Test type: Therapeutic Drug Monitoring, Transplantation

Doctor: Transplant Surgeon, Nephrologist

Test Department: GENETIC

Pre Test Information: Provide date and time of sampling, amount & time of dose. Ideal sampling time: 1 hour before next dose (12 hour trough).

Test Details: Everolimus is a medication that belongs to a class of drugs called mTOR inhibitors. It is used to treat various types of cancer, including advanced breast cancer, advanced kidney cancer, neuroendocrine tumors, and certain types of brain tumors. The drug works by inhibiting the activity of a protein called mTOR (mammalian target of rapamycin), which plays a role in the growth and division of cells. By blocking mTOR, everolimus helps to slow down or stop the growth of cancer cells. Everolimus is typically taken orally in the form of tablets or liquid. The dosage and duration of treatment depend on the type and stage of cancer being treated, as well as other individual factors. Common side effects of everolimus may include mouth sores, diarrhea, nausea, fatigue, and rash. Before starting treatment with everolimus, it is important to discuss any existing medical conditions, medications, or allergies with a healthcare provider. They will also monitor the patient’s blood counts and liver function regularly during treatment. Overall, everolimus is an important treatment option for certain types of cancer and can help improve outcomes and quality of life for patients. However, like any medication, it may have side effects and risks, so it should only be used under the guidance of a healthcare professional.

Test Name	EVEROLIMUS Test
Components
Price	1020.0 AED
Sample Condition	3 mL (2 mL min.) whole blood in 1 Lavender Top (EDTA) tube. Ship refrigerated. Provide date and time of sampling, amount & time of dose. Ideal sampling time: 1 hour before next dose (12 hour trough).
Report Delivery	Sample Daily by 5 pm; Report Same day
Method	LC-MS/MS
Test type	Therapeutic Drug Monitoring, Transplantation
Doctor	Transplant Surgeon, Nephrologist
Test Department:	GENETIC
Pre Test Information	Provide date and time of sampling, amount & time of dose. Ideal sampling time: 1 hour before next dose (12 hour trough).
Test Details	Everolimus is a medication that belongs to a class of drugs called mTOR inhibitors. It is used to treat various types of cancer, including advanced breast cancer, advanced kidney cancer, neuroendocrine tumors, and certain types of brain tumors. The drug works by inhibiting the activity of a protein called mTOR (mammalian target of rapamycin), which plays a role in the growth and division of cells. By blocking mTOR, everolimus helps to slow down or stop the growth of cancer cells. Everolimus is typically taken orally in the form of tablets or liquid. The dosage and duration of treatment depend on the type and stage of cancer being treated, as well as other individual factors. Common side effects of everolimus may include mouth sores, diarrhea, nausea, fatigue, and rash. Before starting treatment with everolimus, it is important to discuss any existing medical conditions, medications, or allergies with a healthcare provider. They will also monitor the patient’s blood counts and liver function regularly during treatment. Overall, everolimus is an important treatment option for certain types of cancer and can help improve outcomes and quality of life for patients. However, like any medication, it may have side effects and risks, so it should only be used under the guidance of a healthcare professional.